Warts Therapeutics Market to Exceed USD 2.5 billion by 2030, Garnering 3.0% CAGR Says, Transparency Market Research
25 sept. 2023 05h37 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The warts therapeutics market was estimated to have acquired US$ 1.92 billion in 2018. It...
Warts Therapeutics Market Size to Outstrip $2,314.60Mn by 2028 Growth Projections at 3.4% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
28 sept. 2021 14h49 HE
|
The Insight Partners
New York, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Warts Therapeutics Market: Key InsightsAccording to our new research study on “Warts Therapeutics Market to 2028 – Global Analysis and Forecast – by...
Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape
26 juil. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, July 26, 2021 (GLOBE NEWSWIRE) -- Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape With...
Global Genital Warts Treatment Market to Surpass US$ 2,253.6 Million by 2028, Says Coherent Market Insights (CMI)
22 juil. 2021 08h40 HE
|
CMI
SEATTLE, July 22, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global genital warts treatment market is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to...
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
24 juil. 2019 08h30 HE
|
Novan, Inc.
Preclinical data published in Antiviral ResearchStudy conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at BirminghamFindings reinforce anti-viral mechanism of...
Novan Publication Supports Women’s Health Business Unit Initiative and Nitric Oxide’s Potential Against HPV-Associated Diseases
01 nov. 2018 08h05 HE
|
Novan, Inc.
Data from SB206 Phase 2 clinical trial in external genital warts have been published in the Journal of Drugs in DermatologySB206 was efficacious and well tolerated in the trialAdvancement of the late...
Hemispherx to Present at the Marcum Microcap Conference in New York
20 mai 2015 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 20, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) will present at the Marcum Microcap Conference being held at the Grand Hyatt Hotel in New York City on Wednesday, May...
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
04 mars 2013 08h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y...